{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:45:45Z","timestamp":1794271545524,"version":"4.9.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Major National Science and Technology Program of China for Innovative Drug","award":["2017ZX09101002-002-003"],"award-info":[{"award-number":["2017ZX09101002-002-003"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.intimp.2018.10.015","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T20:21:31Z","timestamp":1539634891000},"page":"233-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Dihydroartemisinin derivative DC32 attenuates collagen-induced arthritis in mice by restoring the Treg\/Th17 balance and inhibiting synovitis through down-regulation of IL-6"],"prefix":"10.1016","volume":"65","author":[{"given":"Menglin","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2018.10.015_bb0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"5 Suppl. 61","key":"10.1016\/j.intimp.2018.10.015_bb0010","first-page":"S95","article-title":"Side effects and management of side effects of methotrexate in rheumatoid arthritis","volume":"28","author":"Albrecht","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.intimp.2018.10.015_bb0015","first-page":"1","article-title":"Glucocorticoids, inflammation and bone","volume":"3","author":"Guler-Yuksel","year":"2018","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.intimp.2018.10.015_bb0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cyto.2014.10.006","article-title":"The role of the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis pathogenesis and developments in cytokine immunotherapy","volume":"74","author":"Roeleveld","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2018.10.015_bb0025","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2018.10.015_bb0030","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ejps.2012.01.005","article-title":"Topical application of Pseudolaric acid B improve DNFB-induced contact hypersensitivity via regulating the balance of Th1\/Th17\/Treg cell subsets","volume":"45","author":"Li","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2018.10.015_bb0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrrheum.2013.168","article-title":"Emerging cell and cytokine targets in rheumatoid arthritis","volume":"10","author":"Burmester","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2018.10.015_bb0040","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","article-title":"Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis","volume":"233","author":"Bartok","year":"2010","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.intimp.2018.10.015_bb0045","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.autrev.2013.12.004","article-title":"Th17 and regulatory T cell balance in autoimmune and inflammatory diseases","volume":"13","author":"Noack","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.intimp.2018.10.015_bb0050","doi-asserted-by":"crossref","first-page":"R180","DOI":"10.1186\/ar3934","article-title":"Differential effects of Th1 versus Th2 cytokines in combination with hypoxia on HIFs and angiogenesis in RA","volume":"14","author":"Larsen","year":"2012","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.intimp.2018.10.015_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086062","article-title":"EGCG attenuates autoimmune arthritis by inhibition of STAT3 and HIF-1alpha with Th17\/Treg control","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.intimp.2018.10.015_bb0060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.intimp.2018.10.015_bb0065","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/eji.201646565","article-title":"CD11b regulates the Treg\/Th17 balance in murine arthritis via IL-6","volume":"47","author":"Stevanin","year":"2017","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2018.10.015_bb0070","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1074\/jbc.M113.508044","article-title":"A novel CXCR3-B chemokine receptor-induced growth-inhibitory signal in cancer cells is mediated through the regulation of Bach-1 protein and Nrf2 protein nuclear translocation","volume":"289","author":"Balan","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2018.10.015_bb0075","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/14397595.2016.1213481","article-title":"Fractalkine\/CX3CL1 in rheumatoid arthritis","volume":"27","author":"Nanki","year":"2017","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.intimp.2018.10.015_bb0080","doi-asserted-by":"crossref","first-page":"45364","DOI":"10.1038\/srep45364","article-title":"Paroxetine alleviates T lymphocyte activation and infiltration to joints of collagen-induced arthritis","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.intimp.2018.10.015_bb0085","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1002\/art.22208","article-title":"Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis","volume":"54","author":"Matsunawa","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.intimp.2018.10.015_bb0090","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/art.22439","article-title":"Up-regulation of stromal cell-derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L-CD40 interaction","volume":"56","author":"Kim","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2018.10.015_bb0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev-pharmtox-010611-134715","article-title":"Therapeutic targeting of the interleukin-6 receptor","volume":"52","author":"Tanaka","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"7","key":"10.1016\/j.intimp.2018.10.015_bb0100","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/acr.22513","article-title":"Evaluation of serum interleukin-6 level as a surrogate marker of synovial inflammation and as a factor of structural progression in early rheumatoid arthritis: results from a French national multicenter cohort","volume":"67","author":"Baillet","year":"2015","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.intimp.2018.10.015_bb0105","doi-asserted-by":"crossref","first-page":"385352","DOI":"10.1155\/2014\/385352","article-title":"TNFalpha promotes Th17 cell differentiation through IL-6 and IL-1beta produced by monocytes in rheumatoid arthritis","volume":"2014","author":"Zheng","year":"2014","journal-title":"J Immunol Res"},{"issue":"2","key":"10.1016\/j.intimp.2018.10.015_bb0110","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.immuni.2017.01.004","article-title":"Autocrine loop involving IL-6 family member LIF, LIF receptor, and STAT4 drives sustained fibroblast production of inflammatory mediators","volume":"46","author":"Nguyen","year":"2017","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.intimp.2018.10.015_bb0115","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.4049\/jimmunol.1501138","article-title":"IL-17A contributes to the pathogenesis of endometriosis by triggering proinflammatory cytokines and angiogenic growth factors","volume":"195","author":"Ahn","year":"2015","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2018.10.015_bb0120","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s10753-017-0524-6","article-title":"Artesunate protects LPS-induced acute lung injury by inhibiting TLR4 expression and inducing Nrf2 activation","volume":"40","author":"Zhao","year":"2017","journal-title":"Inflammation"},{"issue":"2","key":"10.1016\/j.intimp.2018.10.015_bb0125","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.intimp.2013.03.011","article-title":"Evaluation of the immunosuppressive activity of artesunate in vitro and in vivo","volume":"16","author":"Li","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2018.10.015_bb0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cbi.2015.03.015","article-title":"In vitro and in vivo evaluation of novel cinnamyl sulfonamide hydroxamate derivative against colon adenocarcinoma","volume":"233","author":"Reddy","year":"2015","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.intimp.2018.10.015_bb0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jep.2013.08.019","article-title":"Protective effects of cinnamic acid and cinnamic aldehyde on isoproterenol-induced acute myocardial ischemia in rats","volume":"150","author":"Song","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2018.10.015_bb0140","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejmech.2015.11.003","article-title":"Synthesis and in vitro antitumor evaluation of dihydroartemisinin-cinnamic acid ester derivatives","volume":"107","author":"Xu","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.intimp.2018.10.015_bb0145","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nprot.2007.173","article-title":"Collagen-induced arthritis","volume":"2","author":"Brand","year":"2007","journal-title":"Nat. Protoc."},{"issue":"14","key":"10.1016\/j.intimp.2018.10.015_bb0150","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1111\/bph.12715","article-title":"Methyl salicylate lactoside inhibits inflammatory response of fibroblast-like synoviocytes and joint destruction in collagen-induced arthritis in mice","volume":"171","author":"Xin","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2018.10.015_bb0155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.clim.2014.11.008","article-title":"Pristane primed rat T cells enhance TLR3 expression of fibroblast-like synoviocytes via TNF-alpha initiated p38 MAPK and NF-kappaB pathways","volume":"156","author":"Zhu","year":"2015","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2018.10.015_bb0160","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00775-015-1242-x","article-title":"In vitro effects of binuclear (eta (6)-p-cymene)ruthenium(II) complex containing bridging bis(nicotinate)-polyethylene glycol ester ligand on differentiation pathways of murine Th lymphocytes activated by T cell mitogen","volume":"20","author":"Momcilovic","year":"2015","journal-title":"J. Biol. Inorg. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2018.10.015_bb0165","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1186\/ar3384","article-title":"Arthritis is associated with T-cell-induced upregulation of Toll-like receptor 3 on synovial fibroblasts","volume":"13","author":"Zhu","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.intimp.2018.10.015_bb0170","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/aps.2014.134","article-title":"Artemisinin analogue SM934 ameliorates the proteinuria and renal fibrosis in rat experimental membranous nephropathy","volume":"36","author":"Li","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"10.1016\/j.intimp.2018.10.015_bb0175","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/art.38310","article-title":"Rebamipide suppresses collagen-induced arthritis through reciprocal regulation of th17\/treg cell differentiation and heme oxygenase 1 induction","volume":"66","author":"Moon","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2018.10.015_bb0180","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bcp.2015.11.025","article-title":"Tetrandrine ameliorates collagen-induced arthritis in mice by restoring the balance between Th17 and Treg cells via the aryl hydrocarbon receptor","volume":"101","author":"Yuan","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2018.10.015_bb0185","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.3892\/etm.2017.4232","article-title":"Artesunate influences Th17\/Treg lymphocyte balance by modulating Treg apoptosis and Th17 proliferation in a murine model of rheumatoid arthritis","volume":"13","author":"Liu","year":"2017","journal-title":"Exp. Ther. Med."},{"issue":"7","key":"10.1016\/j.intimp.2018.10.015_bb0190","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/eji.201040391","article-title":"IL-6: regulator of Treg\/Th17 balance","volume":"40","author":"Kimura","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2018.10.015_bb0195","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1681\/ASN.2017091044","article-title":"IL-10 receptor signaling empowers regulatory T cells to control Th17 responses and protect from GN","volume":"29","author":"Diefenhardt","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.intimp.2018.10.015_bb0200","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00281-017-0634-0","article-title":"Cellular and molecular pathways of structural damage in rheumatoid arthritis","volume":"39","author":"Harre","year":"2017","journal-title":"Semin. Immunopathol."},{"issue":"1","key":"10.1016\/j.intimp.2018.10.015_bb0205","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/art.33323","article-title":"Protease-activated receptor 2, rather than protease-activated receptor 1, contributes to the aggressive properties of synovial fibroblasts in rheumatoid arthritis","volume":"64","author":"Xue","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.intimp.2018.10.015_bb0210","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1002\/art.38743","article-title":"Macrophage-derived delta-like protein 1 enhances interleukin-6 and matrix metalloproteinase 3 production by fibroblast-like synoviocytes in mice with collagen-induced arthritis","volume":"66","author":"Sekine","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2018.10.015_bb0215","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.lfs.2015.06.019","article-title":"Andrographolide inhibits the migration, invasion and matrix metalloproteinase expression of rheumatoid arthritis fibroblast-like synoviocytes via inhibition of HIF-1alpha signaling","volume":"136","author":"Li","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2018.10.015_bb0220","first-page":"1","article-title":"Relevance of P-glycoprotein on CXCR4(+) B cells to organ manifestation in highly active rheumatoid arthritis","author":"Tsujimura","year":"2017","journal-title":"Mod. Rheumatol."},{"issue":"6","key":"10.1016\/j.intimp.2018.10.015_bb0225","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.intimp.2018.10.015_bb0230","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.intimp.2018.10.015_bb0235","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/07853890.2013.771986","article-title":"Tocilizumab: a novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases","volume":"45","author":"Alten","year":"2013","journal-title":"Ann. Med."},{"key":"10.1016\/j.intimp.2018.10.015_bb0240","first-page":"1","article-title":"CRISPR and personalized Treg therapy: new insights into the treatment of rheumatoid arthritis","author":"Safari","year":"2018","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"8","key":"10.1016\/j.intimp.2018.10.015_bb0245","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00296-016-3480-9","article-title":"Anti-IL-17 therapy in treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials","volume":"36","author":"Kunwar","year":"2016","journal-title":"Rheumatol. Int."},{"issue":"1","key":"10.1016\/j.intimp.2018.10.015_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jphp.12661","article-title":"Phytoconstituents as pharmacotherapeutics in rheumatoid arthritis: challenges and scope of nano\/submicromedicine in its effective delivery","volume":"69","author":"Rahman","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"issue":"9990","key":"10.1016\/j.intimp.2018.10.015_bb0255","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0140-6736(14)61704-9","article-title":"Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"386","author":"Singh","year":"2015","journal-title":"Lancet"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2018.10.015_bb0260","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2011.06.044","article-title":"Artemisinins and immune system","volume":"668","author":"Shakir","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2018.10.015_bb0265","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11434-015-0975-9","article-title":"Development of artemisinin drugs in the treatment of autoimmune diseases","volume":"61","author":"Wu","year":"2016","journal-title":"Sci. Bull."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918308609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918308609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T20:22:42Z","timestamp":1543263762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918308609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":53,"alternative-id":["S1567576918308609"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2018.10.015","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dihydroartemisinin derivative DC32 attenuates collagen-induced arthritis in mice by restoring the Treg\/Th17 balance and inhibiting synovitis through down-regulation of IL-6","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2018.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}